Please try another search
By David Carnevali NEW YORK (Reuters) - Investors are scrambling to assess the fallout of a U.S. regulatory challenge against Amgen Inc (NASDAQ:AMGN)'s proposed $27.8 billion acquisition of Horizon...
Investing.com – U.S. stocks were higher after the close on Monday, as gains in the Healthcare sectors led shares higher. At the close in NYSE, the NASDAQ Composite index gained 1.01%. The best...
Investing.com – U.S. stocks were higher after the close on Wednesday, as gains in the Healthcare sectors led shares higher. At the close in NYSE, the NASDAQ Composite index gained 0.33%. The best...
IVERIC bio (NASDAQ:FCSC) and Editas Medicine, Inc. (NASDAQ:EDIT) . While Celsion and Fibrocell sport a Zacks Rank #1 (Strong Buy), Editas carries a Zacks Rank #2 (Buy). You can see the complete...
IVERIC bio (NASDAQ:ALXN) and Acorda Therapeutics (NASDAQ:ACOR) . While Axovantand Acorda sport a Zacks Rank #1 (Strong Buy), Alexion carries a Zacks Rank #2 (Buy). You can see the complete list of...
Put to call ratios are a permanent fixture in my indicator stable and something I have been writing about for a number of years, including an early 2007 effort, A Sentiment Primer (Long). My...
Instrument Type
Region
Sector
Industry
Date
Category
Provider